A group of novel VEGF splice variants as alternative therapeutic targets in renal cell carcinoma

A group of novel VEGF splice variants as alternative therapeutic targets in renal cell carcinoma

The efficacy of anti‐angiogenic treatment by targeting VEGF/VEGF receptors in metastatic clear cell renal cell carcinoma (ccRCC) varies from patient to patient. Discovering the reasons behind this variability could lead to the identification of relevant therapeutic targets. Thus, we investigated the...

Full description

Bibliographic Details
Main Authors: Christopher Montemagno, Jérôme Durivault, Cécile Gastaldi, Maeva Dufies, Valérie Vial, Xingkang He, Damien Ambrosetti, Anna Kamenskaya, Sylvie Negrier, Jean‐Christophe Bernhard, Delphine Borchiellini, Yihai Cao, Gilles Pagès
Format: Article
Language:English
Published: Wiley 2023-07-01
Series:Molecular Oncology
Subjects:
alternative splicing
angio/lymphangiogenesis
renal cell carcinoma
resistance to antiangiogenics
VEGF
Online Access:https://doi.org/10.1002/1878-0261.13401

Internet

https://doi.org/10.1002/1878-0261.13401

Similar Items